CureVac (CVAC) News Today $3.56 +0.16 (+4.71%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$3.63 +0.07 (+1.97%) As of 08:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period CureVac (NASDAQ:CVAC) Shares Gap Up - Should You Buy?CureVac (NASDAQ:CVAC) Shares Gap Up - Time to Buy?May 5 at 2:53 AM | marketbeat.comCureVac (NASDAQ:CVAC) Shares Gap Up - Here's What HappenedMay 4 at 2:49 AM | americanbankingnews.comCureVac (NASDAQ:CVAC) Price Target Lowered to $12.00 at UBS GroupUBS Group decreased their target price on shares of CureVac from $13.00 to $12.00 and set a "buy" rating on the stock in a research report on Wednesday.May 2 at 10:52 AM | marketbeat.comCureVac (NASDAQ:CVAC) Price Target Cut to $12.00 by Analysts at UBS GroupMay 2 at 2:49 AM | americanbankingnews.comCureVac (NASDAQ:CVAC) Shares Up 7.7% - Still a Buy?CureVac (NASDAQ:CVAC) Trading 7.7% Higher - Time to Buy?April 30, 2025 | marketbeat.comCureVac (CVAC) Target Price Reduced by UBS Analyst | CVAC Stock NewsApril 30, 2025 | gurufocus.comCureVac (NASDAQ:CVAC) Shares Gap Up - Here's WhyCureVac (NASDAQ:CVAC) Shares Gap Up - Should You Buy?April 27, 2025 | marketbeat.comCureVac (NASDAQ:CVAC) Sees Significant Increase in Short InterestCureVac (NASDAQ:CVAC - Get Free Report) saw a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 4,850,000 shares, a growth of 19.5% from the March 15th total of 4,060,000 shares. Based on an average trading volume of 812,400 shares, the short-interest ratio is presently 6.0 days. Approximately 5.2% of the shares of the company are sold short.April 23, 2025 | marketbeat.comCureVac (CVAC) to Release Quarterly Earnings on WednesdayCureVac (NASDAQ:CVAC) will be releasing earnings before the market opens on Wednesday, April 23, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=514050)April 17, 2025 | marketbeat.comCureVac (NASDAQ:CVAC) Posts Earnings ResultsCureVac (NASDAQ:CVAC - Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.15) EPS for the quarter. The company had revenue of $15.44 million for the quarter. CureVac had a return on equity of 21.98% and a net margin of 20.72%.April 14, 2025 | marketbeat.comCureVac’s Financial Resilience Amid Operational Challenges and Clinical Trial Uncertainties: A Hold Rating AnalysisApril 14, 2025 | tipranks.comCureVac N.V. (NASDAQ:CVAC) Q4 2024 Earnings Call TranscriptApril 12, 2025 | insidermonkey.comCureVac N.V. Earnings Call: Financial Strength Amid ChallengesApril 11, 2025 | tipranks.comQ4 2024 CureVac NV Earnings CallApril 11, 2025 | uk.finance.yahoo.comCureVac’s Promising Pipeline and Legal Wins Justify Buy RatingApril 11, 2025 | tipranks.comCureVac NV (CVAC) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Financial ResilienceApril 11, 2025 | finance.yahoo.comCureVac Stock (CVAC) Dips Despite Promising Treatment PipelineApril 11, 2025 | tipranks.comCureVac reports Q4 revenue EUR 14.5M vs. EUR 22.6M last yearApril 10, 2025 | markets.businessinsider.comCureVac Reports 2024 Financial Results and Strategic AdvancesApril 10, 2025 | tipranks.comEQS-News: CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2024 and Provides Business UpdateApril 10, 2025 | markets.businessinsider.comCureVac Stock Declines On Weaker-Than-Expected Q4 Revenue: Retail’s On Wait-And-Watch ModeApril 10, 2025 | msn.comCureVac N.V. (CVAC) Q4 2024 Earnings Call TranscriptApril 10, 2025 | seekingalpha.comCureVac N.V. 2024 Q4 - Results - Earnings Call PresentationApril 10, 2025 | seekingalpha.comCureVac Announces Financial Results for the Fourth Quarter and Full-Year 2024 and Provides ...April 10, 2025 | gurufocus.comCureVac Announces Financial Results for the Fourth Quarter and Full-Year 2024 and Provides ...April 10, 2025 | gurufocus.comCureVac (CVAC) Strengthens Financial Position to Boost mRNA Innovation | CVAC Stock NewsApril 10, 2025 | gurufocus.comGSK Deal Boosts CureVac's (CVAC) Cash Reserves, Ensures Financial Stability | CVAC Stock NewsApril 10, 2025 | gurufocus.comInsights Ahead: CureVac's Quarterly EarningsApril 9, 2025 | benzinga.comCureVac receives IND clearance to initiate Phase 1 trial for CVHNLCApril 8, 2025 | markets.businessinsider.comCureVac Receives FDA Clearance for Phase 1 Trial of mRNA ImmunotherapyApril 7, 2025 | tipranks.comCureVac Receives U.S. FDA IND Clearance to Initiate Phase 1 Clinical Trial for Novel mRNA-Based ...April 7, 2025 | gurufocus.comIs CureVac (CVAC) the Best German Stock to Buy According to Hedge Funds?April 2, 2025 | msn.comCureVac (NASDAQ:CVAC) Stock Price Down 7.2% - What's Next?CureVac (NASDAQ:CVAC) Stock Price Down 7.2% - What's Next?April 1, 2025 | marketbeat.comCureVac (CVAC) Gets a Hold from Leerink PartnersMarch 31, 2025 | markets.businessinsider.com12 Best German Stocks to Buy According to Hedge FundsMarch 30, 2025 | insidermonkey.comCureVac (NASDAQ:CVAC) Sees Strong Trading Volume - Time to Buy?CureVac (NASDAQ:CVAC) Sees Large Volume Increase - Still a Buy?March 29, 2025 | marketbeat.comCureVac’s amended patent upheld by European Patent OfficeMarch 29, 2025 | investing.comLululemon, General Motors and Apple fall premarket; CureVac gainsMarch 28, 2025 | investing.comCureVac says European Patent Office dismissed BioNTech oppositionMarch 28, 2025 | markets.businessinsider.comEuropean Patent Office Rules Vaccine Developer CureVac's Amended Patent Valid, Stock JumpsMarch 28, 2025 | benzinga.comCureVac (CVAC) Surges as European Court Validates Key PatentMarch 27, 2025 | gurufocus.comEuropean Patent Office declares CureVac mRNA patent validMarch 27, 2025 | reuters.comCureVac Wins Patent Ruling Against BioNTechMarch 27, 2025 | tipranks.comCureVac stock rises on positive patent ruling against BioNTechMarch 27, 2025 | in.investing.comCureVac (NASDAQ:CVAC) Shares Gap Up - Time to Buy?CureVac (NASDAQ:CVAC) Shares Gap Up - Should You Buy?March 26, 2025 | marketbeat.comCureVac (NASDAQ:CVAC) Trading Up 9.1% - Still a Buy?CureVac (NASDAQ:CVAC) Shares Up 9.1% - Here's WhyMarch 12, 2025 | marketbeat.comCureVac N.V.'s (NASDAQ:CVAC) largest shareholders are individual investors with 38% ownership, private equity firms own 31%March 10, 2025 | finance.yahoo.comCureVac (NASDAQ:CVAC) Shares Gap Down - Here's WhyCureVac (NASDAQ:CVAC) Shares Gap Down - What's Next?March 8, 2025 | marketbeat.comCureVac (NASDAQ:CVAC) Stock Price Down 6.1% - What's Next?CureVac (NASDAQ:CVAC) Stock Price Down 6.1% - Here's WhyFebruary 22, 2025 | marketbeat.comCureVac (NASDAQ:CVAC) Trading Down 6.1% - Time to Sell?CureVac (NASDAQ:CVAC) Shares Down 6.1% - Here's WhyFebruary 20, 2025 | marketbeat.com Get CureVac News Delivered to You Automatically Sign up to receive the latest news and ratings for CVAC and its competitors with MarketBeat's FREE daily newsletter. Email Address CVAC Media Mentions By Week CVAC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CVAC News Sentiment▼0.190.73▲Average Medical News Sentiment CVAC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CVAC Articles This Week▼73▲CVAC Articles Average Week Get CureVac News Delivered to You Automatically Sign up to receive the latest news and ratings for CVAC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CRNX News Today SRRK News Today VKTX News Today XENE News Today CPRX News Today MOR News Today PTGX News Today HCM News Today IMVT News Today MLTX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CVAC) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CureVac Please log in to your account or sign up in order to add this asset to your watchlist. Share CureVac With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CVAC Stock Free CVAC Stock Alerts